Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$65.58T
24h Vol:
$10.74B
Dominance:
MSFT:4.76%
Stocklytics Platform
Asset logo  ZTS
Zoetis
ZTS
68 / 100
S&P500
$174.06arrow_drop_up0.20%$0.34

Performance History

Stocklytics logo
Key Stats
Open$174.05
Prev. Close$173.71
EPS5.19
Dividend$1.61
Next Earnings DateSep 9, 2024
Dividend Yield %0.99%
Market Cap$77.13B
PE Ratio33.54
LOWHIGH
Day Range172.58
174.66
52 Week Range144.80
201.92
Ratios
P/B Ratio13.71
Revenue$8.54B
Operating M. %36.58%
Earnings$2.34B
Earnings Growth %11.04%
EBITDA Margin %41.75%
ROE %50.05%
EPS5.19

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$770.00
24H (%)arrow_drop_down0.14%
24H ($)-$1.12
MARKET CAP$722.30B
PRICE$524.63
24H (%)arrow_drop_up0.64%
24H ($)$3.35
MARKET CAP$471.98B
PRICE$154.64
24H (%)arrow_drop_up0.23%
24H ($)$0.36
MARKET CAP$360.78B
PRICE$131.19
24H (%)arrow_drop_up0.23%
24H ($)$0.31
MARKET CAP$329.41B

About Zoetis (ZTS)

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Ms. Kristin C. Peck
Headquarters
Parsippany
Employees
13800
Exchange
NYSE
add Zoetis  to watchlist

Keep an eye on Zoetis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Zoetis 's (ZTS) price per share?

The current price per share for Zoetis (ZTS) is $174.06. The stock has seen a price change of $0.35 recently, indicating a 0.2% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Zoetis (ZTS)?

For Zoetis (ZTS), the 52-week high is $201.92, which is 16.01% from the current price. The 52-week low is $144.8, the current price is 20.21% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Zoetis (ZTS) a growth stock?

Zoetis (ZTS) has shown an average price growth of 0.41% over the past three years. It has received a score of 48 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Zoetis as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Zoetis (ZTS) stock price performance year to date (YTD)?

As of the latest data, Zoetis (ZTS) has a year-to-date price change of -11.45%. Over the past month, the stock has experienced a price change of 14.56%. Over the last three months, the change has been -6.7%. Over the past six months, the figure is -0.42%. Looking at a longer horizon, the five-year price change stands at 70.7%.

help
Is Zoetis (ZTS) a profitable company?

Zoetis (ZTS) has a net income of $2.34B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.28% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 36.58% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $8.54B, with a revenue growth rate of 5.74%, providing insight into the company's sales performance and growth. The gross profit is $5.83B. Operating income is noted at $3.07B. Furthermore, the EBITDA is $3.74B.

help
What is the market capitalization of Zoetis (ZTS)?

Zoetis (ZTS) has a market capitalization of $77.13B. The average daily trading volume is 2.57M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level